D-1178-2017 Class II Terminated
FDA drug recall D-1178-2017 was initiated by Teva Pharmaceuticals USA on September 5, 2017 and is designated Class II. Reason for recall: Labeling: Incorrect or Missing Lot and/or Exp Date: An incorrect expiration date of July 2018 is printed on the product labeling rather than the correct expiration date of July 2017. The recall status is terminated (terminated June 21, 2018). Affected quantity: 3,275 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- October 4, 2017
- Initiation Date
- September 5, 2017
- Termination Date
- June 21, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3,275 bottles
Product Description
Acarbose Tablets, 25 mg, 100-count bottle, Rx only, Manufactured by: Arrow Pharm (Malta) Ltd., Birzebbugia BBG3000, Malta; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054; NDC 16252-523-01.
Reason for Recall
Labeling: Incorrect or Missing Lot and/or Exp Date: An incorrect expiration date of July 2018 is printed on the product labeling rather than the correct expiration date of July 2017.
Distribution Pattern
Nationwide in the USA
Code Information
Lot #: 1082710A, Exp 07/18